Advances in Asian Pediatric Respiratory and Neonatal Care

Résumé fourni par la source

In this issue, there is a total of five insightful articles include the current advances in pediatric respiratory medicine and neonatal intensive care. The pediatric topics range from the diagnostic challenges of rare genetic disorders of diverse populations to the emerging preventive therapies such as respiratory syncytial virus (RSV) prophylaxis. These works provide the importance of precision, timely intervention, and regional needs in enhancing child health outcomes. A major issue is the detection and management of chronic airway diseases, cystic fibrosis (CF). CF has been considered rare in Asian populations; however, the review by Al-Kindi[1] questions this assumption and suggests that CF may be significantly underdiagnosed across the Asian region. The author points out that Asia’s diverse ethnic backgrounds and varying healthcare systems may lead to considerable differences in disease prevalence and genetic patterns. Notably, it has been reported that CFTR mutation profiles in Asian populations differ from those who in Western countries, reducing the effectiveness of standard mutation panels and limits access to therapies.[2] This highlights the need for region-specific diagnostic approaches and access to affordable sweat testing to avoid delayed diagnoses for leading to severe malnutrition and early death. Considerable attention has been given to CF treatment, but managing non-CF bronchiectasis (NCFBE) still presents distinct challenges. In a pilot study in this issue, Dr. Nathan and colleagues explored the use of inhaled antibiotics for treating NCFBE exacerbations in children.[3] While inhaled antibiotics are widely used in CF, this study found that they had limited benefit when used alone for NCFBE exacerbations. In contrast, patients receiving both systemic and inhaled antibiotics showed improvements in cough severity and quality of life. Dr. Nathan’s findings suggest that treatment approaches for CF exacerbations cannot simply be applied to NCFBE, especially when systemic therapy is not included. In clinical practice, a major goal in pediatric respiratory care is to detect lung disease early. However, conventional spirometry is often limited by its low sensitivity and applicability in older children. In this issue, Dr. Welsh highlights another important advance in diagnostic approaches in Multiple Breath Washout and the Lung Clearance Index,[4] which offers a noninvasive alternative that can be used across all age groups, including infants. Dr. Welsh highlights recent advances in the developments of improving the feasibility and accessibility of diagnostic pulmonary function for clinical use of detecting ventilation abnormalities earlier. The needs of the developing child, particularly in preterm infants, are especially evident in the neonatal intensive care unit. In this issue, Patil et al.[5] report an original study evaluating cranial ultrasonography (CUS) in preterm neonates. Preterm infants were found to have a high risk of neurological injury, including germinal matrix hemorrhage, which was seen in 27% of the cohort. The study also observed a clear association between lower birth weight and increased neonatal mortality. However, abnormal findings on CUS were not independently linked to mortality. These results suggest that while CUS is valuable for detecting brain injury, survival in preterm infants is still driven mainly by broader perinatal factors such as birth asphyxia and respiratory distress. Preventive strategies for RSV, a major cause of infant hospitalizations worldwide, aim to reduce disease burden through timely prophylaxis and early protection in infancy. In this issue, Yip[6] presents a narrative review on the practical use of Nirsevimab, a long-acting monoclonal antibody, with a focus on its application in Hong Kong. Unlike Palivizumab, Nirsevimab can provide protection for the entire RSV season with a single dose. However, in a densely populated setting like Hong Kong, implementation requires a specific approach due to variable RSV seasonality and the structure of the public health system. The author suggests a locally adapted model delivered through Maternal and Child Health Centers, with a phased rollout designed to improve equitable access. This article provides an important reminder that while global medical advances are valuable, they need to be adapted to local epidemiology and healthcare systems to achieve meaningful real-world impact. Overall, the articles in this issue reflect the wide-ranging scope of modern pediatric care. They range from improving our understanding of genetic disease patterns in Asian populations, to assessing nebulized treatment strategies, introducing more sensitive tools for lung function assessment, and refining approaches to the prophylaxis of neonatal RSV infection. These studies strengthen the evidence base for clinical practice and emphasize that improving child health outcomes requires not only global innovation, but also careful local adaptation and sustained attention to early and accurate diagnosis. Financial support and sponsorship Nil. Conflicts of interest There are no conflicts of interest.

Ce résumé expose les affirmations des auteurs. BNTIC ne l’interprète pas comme une validation indépendante des résultats.